EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial

Rebecca J Moon, Stefania D'Angelo, Elizabeth M Curtis, Kate A Ward, Keith M Godfrey, Cyrus Cooper, Nicholas C Harvey

Osteoporosis International · 2025

DOI: 10.1007/s00198-025-07568-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2025. Verfasst von Rebecca J Moon und 6 weiteren Autor:innen. Beteiligte Einrichtung: MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. rm@mrc.soton.ac…. Hauptthemen laut MEDLINE: Bone Density, Cholecalciferol, Dietary Supplements, Bone Density Conservation Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Versus Arthritis, Medical Research Council, Bupa Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effect of pregnancy vitamin D supplementation on bone mineral density (BMD) in the mother immediately after delivery and at 4 years after delivery was assessed in a randomised placebo-controlled trial. The mothers' BMD did not differ between the two intervention groups. PURPOSE: Vitamin D supplementation during pregnancy has positive effects on the offspring's bone development and bone mineral density (BMD) in childhood, but there are limited data on the effects on the mother's skeleton. We assessed this in a post hoc follow-up of a randomised trial. METHODS: MAVIDOS was a randomised placebo-controlled trial of 1000 IU/day cholecalciferol from 14 to 17 weeks gestation until delivery. Participants were invited to have a dual-energy X-ray absorptiometry (DXA) scan of the whole body, lumbar spine (LS) and left hip within 2 weeks after delivery and again 4 years after delivery. BMD was compared between the cholecalciferol and placebo groups; in women with DXA at both time points, the effect of cholecalciferol was assessed using mixed effects modelling to account for repeated measures. RESULTS: Four hundred one and 443 participants had a DXA within 2 weeks after delivery and at a mean of 4.1 years after delivery, respectively. Cholecalciferol supplementation increased serum 25-hydroxyvitamin D status in late pregnancy compared to placebo. BMD at all sites was similar between the two randomisation groups at both time points (p > 0.05 for all). Two hundred sixty-three participants had a DXA at both birth and 4 years. BMD increased between 1 and 6% depending on the site from within 2 weeks to 4 years after delivery. This was similar between randomisation groups. The pregnancy cholecalciferol had no effect on BMD at 4 years in repeated measures modelling. CONCLUSIONS: Despite previously demonstrated benefits for the offspring skeleton in this trial, maternal BMD did not differ in the short or medium term in women randomised to 1000 IU/day vitamin D or placebo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityCholecalciferolDietary SupplementsBone Density Conservation AgentsHumansFemalePregnancyAbsorptiometry, PhotonAdultLumbar VertebraeYoung AdultFollow-Up StudiesHip JointPrenatal CareVitamin D

Stichwörter der Autor:innen

Bone mineral densityCholecalciferolEpidemiologyOsteoporosisPregnancyVitamin D

Substanzen

CholecalciferolBone Density Conservation AgentsVitamin D

Autor:innen und Institutionen

  • MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. rm@mrc.soton.ac.uk.
  • Paediatric Endocrinology, Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. rm@mrc.soton.ac.uk.
  • NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. rm@mrc.soton.ac.uk.
  • MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
  • MRC Versus Arthritis Centre for Musculoskeletal Health and Work, MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.

Förderung

  • Versus Arthritis
  • Medical Research Council
  • Bupa Foundation
  • National Institute for Health Research Southampton Biomedical Research Centre
  • National Institute for Health and Care Research
  • Wellcome Trust
  • Rosetrees Trust

Zitieren

APA

Moon, R. J., D'Angelo, S., Curtis, E. M., Ward, K. A., Godfrey, K. M., Cooper, C., & Harvey, N. C. (2025). Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial. Osteoporosis International. https://doi.org/10.1007/s00198-025-07568-0

Vancouver

Moon RJ, D'Angelo S, Curtis EM, Ward KA, Godfrey KM, Cooper C, et al. Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial. Osteoporosis International. 2025. doi:10.1007/s00198-025-07568-0

BibTeX
@article{Moon2025,
  author = {Moon, Rebecca J and D'Angelo, Stefania and Curtis, Elizabeth M and Ward, Kate A and Godfrey, Keith M and Cooper, Cyrus and Harvey, Nicholas C},
  title = {Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial},
  journal = {Osteoporosis International},
  year = {2025},
  doi = {10.1007/s00198-025-07568-0}
}
Kostenlos starten →